Xeris Biopharma Holdings, Inc. XERS Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s inventories?
- Xeris Biopharma Holdings, Inc. (XERS) reported inventories of $74.23M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s inventories changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s inventories increased by 40.9% year-over-year, from $52.69M to $74.23M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s inventories?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s inventories has grown at a 52.4% compound annual growth rate (CAGR), from $8.35M to $68.67M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.